E Fund Management Co., Ltd. G1 Therapeutics, Inc. Transaction History

E Fund Management Co., Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$4.04 - $8.51 $51,990 - $109,515	-12,869 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$7.6 - $11.02 $11,719 - $16,992	1,542 Added 13.61%	12,869 $98,000
Q4 2021 Feb 11, 2022	SELL	$10.16 - $16.17 $2,844 - $4,527	-280 Reduced 2.41%	11,327 $116,000
Q3 2021 Nov 12, 2021	BUY	$13.16 - $22.47 $74,604 - $127,382	5,669 Added 95.47%	11,607 $156,000
Q1 2021 May 12, 2021	BUY	$17.58 - $32.59 $104,390 - $193,519	5,938 New	5,938 $142,000

101

20.1M

1.87M

1.18M

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

Get notified when there are updates to the investment portfolio of E Fund Management Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on E Fund Management Co., Ltd. with notifications on news.